Erasmus University Medical Center, Department of Cardiology, Rotterdam, The Netherlands.
J Biomed Opt. 2023 Dec;28(12):121205. doi: 10.1117/1.JBO.28.12.121205. Epub 2023 Jun 8.
SIGNIFICANCE: Photoacoustic imaging (PAI) enables the visualization of optical contrast with ultrasonic imaging. It is a field of intense research, with great promise for clinical application. Understanding the principles of PAI is important for engineering research and image interpretation. AIM: In this tutorial review, we lay out the imaging physics, instrumentation requirements, standardization, and some practical examples for (junior) researchers, who have an interest in developing PAI systems and applications for clinical translation or applying PAI in clinical research. APPROACH: We discuss PAI principles and implementation in a shared context, emphasizing technical solutions that are amenable to broad clinical deployment, considering factors such as robustness, mobility, and cost in addition to image quality and quantification. RESULTS: Photoacoustics, capitalizing on endogenous contrast or administered contrast agents that are approved for human use, yields highly informative images in clinical settings, which can support diagnosis and interventions in the future. CONCLUSION: PAI offers unique image contrast that has been demonstrated in a broad set of clinical scenarios. The transition of PAI from a "nice-to-have" to a "need-to-have" modality will require dedicated clinical studies that evaluate therapeutic decision-making based on PAI and consideration of the actual value for patients and clinicians, compared with the associated cost.
意义:光声成像是一种利用超声成像来可视化光学对比度的技术。它是一个研究热点领域,在临床应用方面具有巨大的潜力。了解光声成像的原理对于工程研究和图像解释都很重要。
目的:在本教程综述中,我们为有兴趣开发用于临床转化的光声成像系统和应用,或在临床研究中应用光声成像的(初级)研究人员,阐述了成像物理、仪器要求、标准化以及一些实际示例。
方法:我们在共享的上下文中讨论光声成像的原理和实现,强调了易于广泛临床部署的技术解决方案,除了图像质量和量化之外,还考虑了稳健性、移动性和成本等因素。
结果:光声成像是利用内源性对比或已批准用于人体的外源性对比剂来实现的,它可以在临床环境中提供非常有价值的图像,未来可以支持诊断和干预。
结论:光声成像提供了独特的图像对比度,已经在广泛的临床场景中得到了证明。要将光声成像从“锦上添花”转变为“必不可少”的模式,需要进行专门的临床研究,根据光声成像来评估治疗决策,并考虑患者和临床医生的实际价值,以及相关成本。
J Biomed Opt. 2024-8
Tissue Eng Part B Rev. 2020-2
J Biomed Opt. 2021-4
Nat Rev Clin Oncol. 2022-6
Ultrasonics. 2024-4
Sensors (Basel). 2024-4-23
Curr Drug Targets. 2015
J Biomed Opt. 2024-1
Sensors (Basel). 2025-8-5
J Nanobiotechnology. 2025-3-5
Photoacoustics. 2024-12-19
3 Biotech. 2024-11
Bioengineered. 2024-12
Sensors (Basel). 2023-1-2
J Biophotonics. 2023-4
Nat Commun. 2022-8-1
Photoacoustics. 2022-2-26